Integra LifeSciences Holdings Corp. (IART) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Globus Medical, Inc.

Glaukos Corp.

Sotera Health Co.

Sanmina Corp.

Neogen Corp.

Merit Medical Systems, Inc.

Haemonetics Corp.

Envista Holdings Corp.

Lantheus Holdings, Inc.

Integra LifeSciences Holdings Corp.

Inari Medical, Inc.

Why is Integra LifeSciences Holdings Corp. ?

Poor long term growth as Operating profit has grown by an annual rate -4.85% of over the last 5 years

Negative results in Jun 25

OPERATING CASH FLOW(Y) Lowest at USD 70.88 MM
ROCE(HY) Lowest at -38.92%
INTEREST(Q) At USD 22.48 MM has Grown at 11.04%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -45.34%, its profits have risen by 18.4% ; the PEG ratio of the company is 0.5

Reducing Promoter Confidence

Promoters have decreased their stake in the company by -0.87% over the previous quarter and currently hold 1.03% of the company
Promoters decreasing their stake may signify reduced confidence in the future of the business

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -45.34% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Integra LifeSciences Holdings Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Integra LifeSciences Holdings Corp.

-44.9%

-0.91

62.56%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.17%

EBIT Growth (5y)

-4.85%

EBIT to Interest (avg)

5.10

Debt to EBITDA (avg)

3.74

Net Debt to Equity (avg)

1.04

Sales to Capital Employed (avg)

0.49

Tax Ratio

32.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

7.88%

ROE (avg)

10.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.73

EV to EBIT

18.47

EV to EBITDA

9.20

EV to Capital Employed

0.87

EV to Sales

1.66

PEG Ratio

0.53

Dividend Yield

ROCE (Latest)

4.71%

ROE (Latest)

7.03%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

NET PROFIT(Q)

Highest at USD 66.2 MM

-12What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD 70.88 MM

ROCE(HY)

Lowest at -38.92%

INTEREST(Q)

At USD 22.48 MM has Grown at 11.04%

RAW MATERIAL COST(Y)

Grown by 8.14% (YoY

CASH AND EQV(HY)

Lowest at USD 526.9 MM

DEBT-EQUITY RATIO (HY)

Highest at 169.46 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.62 times

EPS(Q)

Lowest at USD -6.31

Here's what is working for Integra LifeSciences Holdings Corp.

Net Profit

At USD 66.2 MM has Grown at 142.91%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Profit

Highest at USD 66.2 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Depreciation

Highest at USD 37.69 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Integra LifeSciences Holdings Corp.

Operating Cash Flow

Lowest at USD 70.88 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest

At USD 22.48 MM has Grown at 11.04%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

EPS

Lowest at USD -6.31

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv

Lowest at USD 526.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 169.46 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.62 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 8.14% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales